CN1435223A - Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation - Google Patents
Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN1435223A CN1435223A CN 02135827 CN02135827A CN1435223A CN 1435223 A CN1435223 A CN 1435223A CN 02135827 CN02135827 CN 02135827 CN 02135827 A CN02135827 A CN 02135827A CN 1435223 A CN1435223 A CN 1435223A
- Authority
- CN
- China
- Prior art keywords
- herba
- swelling
- stasis
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
An exterior-applied Chinese medicine for treating chronic pelvic inflammation is prepared from 12 Chinese-medicinal materials including peach kernel, safflower, Chinese angelica root, Chuan-xiong rhizome, etc. Its advantages are sure curative effect, and quickly taking its effect.
Description
Technical field:
The invention belongs to medical technical field, is the externally applied medicinal stasis-and swelling-eliminating powder of a kind of Chinese medicine chronic pelvic inflammatory disease (being chronic salpingitis, hydrosalpinx and tubo-ovarian cyst, chronic pelvic paramitritis).
The pathogeny of chronic pelvic inflammatory disease:
Chronic salpingitis mostly is bilateral, can involve ovary later on, in inflammatory process, tubal wall thickens hardening, mucous layer has inflammatory exudation, can stick together, and tube chamber is blocked, if umbrella end and isthmus adhesion, transudate amasss in tube chamber and forms hydrosalpinx or elder generation's formation empyema, becomes hydrops again, and egg capsule is if get involved simultaneously, and with the fallopian tube break-through, feasible again one-tenth fallopian tube egg capsule is swollen.
Chronic pelvic paramitritis is that acute inflammation involves both sides, uterus connective tissue and cardinal ligament etc. and locates, and develops because of failing to cure, owing to organize congestion and edema, hypertrophy, hardening, is fan-shaped and reaches pelvic cavity to external diffusion, and the uterus is fixed, and the state of an illness obstinate being difficult for cures.
Background technology:
At present, the traditional Chinese medical science thinks due to damp-heat blocking in the body, stagnation of QI blood block up, the deficiency of the liver and kindey more, how with the oral medicine of clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain, liver and kidney tonifying, removing toxic substances and promoting subsidence of swelling for controlling.The hardship of patient Duo Yin the intestines and stomach stimulation and inconvenience and relaxation treatment.Physiotherapy commonly used has: ultrasound wave, hydrotherapy, wax therapy, infrared ray, acupoint injection therapy etc. also manyly lose best occasion for the treatment because of the patient can not adhere to limitting with medical condition.Western medicine adopts anti-inflammation treatment more, because of the course of treatment long, easily recurrence and the patient lacks treatment confidence, final many employing operative treatments.Swollen with ovary is example (average about 3000 yuan of County Hospital excision does not contain the cost of living, nurse fees, charge for loss of working time and labour value).But operative treatment is the expense height not only, and the misery that causes to the patient is big.
Summary of the invention:
The objective of the invention is to develop the externally applied medicinal stasis-and swelling-eliminating powder of a kind of short treating period, instant effect, no pain, economy Chinese traditional treatment chronic pelvic inflammatory disease easily.
The present invention controls and the modern pharmacology analytical test according to the dialectical opinion of the traditional Chinese medical science, select for use have blood circulation promoting and blood stasis dispelling, the Chinese herbal medicine of function such as promoting the circulation of QI to relieve pain, removing heat from blood detumescence, anti-inflammation, and adopt rational composition of prescription.
Removing blood stasis detumescence of the present invention is loose and is made up of following medicine, and its formulation ratio relation (proportioning employing weight portion) Semen Persicae 30-60, Flos Carthami 40-80, Radix Angelicae Sinensis 50-90, Rhizoma Chuanxiong 50-70, Radix Salviae Miltiorrhizae 40-80, Cortex Moutan 50-100, Herba Leonuri 60-100, Herba Patriniae 50-100, Herba Lycopi's grass 40-80, Herba Lysimachiae 40-90, Rhizoma Cyperi 50-70, Radix Aucklandiae 50-80 12 flavor medicines are formed.
In the prescription of this medicine, Semen Persicae: blood circulation promoting and blood stasis dispelling has the anticoagulant effect.
Flos Carthami: blood stasis dispelling stimulates the menstrual flow.
Radix Angelicae Sinensis: the promoting blood circulation and stopping pain of enriching blood, make the uterus speed to delay, improve blood circulation, be beneficial to antiinflammatory.
Rhizoma Chuanxiong: promoting flow of QI and blood, there is the enhancing contraction in the uterus.
Cortex Moutan: clearing away heat and cooling blood, dissipating blood stasis, antiphlogistic antibacterial.
Radix Salviae Miltiorrhizae: promoting blood circulation and detumescence, improve blood obturation, antiphlogistic antibacterial.
Herba Leonuri: blood circulation promoting and blood stasis dispelling, swelling diuretic, there is significant excitation in the uterus.
Herba Lycopi's grass: line water detumescence.
Herba Patriniae: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, antivirus action is arranged.
Radix Rubiae: cooling blood for hemostasis, strengthen uterine contraction, bacteriostasis is arranged.
Herba Lysimachiae: clearing away heat-damp and promoting diuresis, detumescence, detoxifcation, antibacterial.
Rhizoma Cyperi, the Radix Aucklandiae: promoting the circulation of QI to relieve pain, priming are descending.
" monarch " relation according to compatibility of drugs:
Monarch drug: Semen Persicae, Flos Carthami, Radix Angelicae Sinensis, Rhizoma Chuanxiong
Ministerial drug; Radix Salviae Miltiorrhizae, Cortex Moutan, Herba Leonuri
Adjuvant drug: Herba Patriniae, Herba Lycopi's grass, Herba Lysimachiae
Messenger drug: Rhizoma Cyperi, the Radix Aucklandiae
According to above-mentioned 12 its functions of herbal medicine analysis-by-synthesis and curing mainly;
Pharmic function: blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, clearing away heat and cooling blood, subduing swelling and detoxicating, antibiotic, antiinflammatory.
Cure mainly: chronic pelvic inflammatory disease, often fail treatment in time thoroughly or, due to the characteristic of disease delay because patient is vulnerable because of acute pelvic inflammatory disease.Also some people's onset is slow, and ignorance is treated and formed.The traditional Chinese medical science is thought surplus heresy not to the greatest extent more, among the long-pending born of the same parents of the stasis of blood, so that visceral dysfunction, disorder of QI and blood causes towards appointing impaired.The 12 flavor Chinese herbal medicine that side of the present invention selects for use penetrate by preferred, purification, pulverizing, physical heating, tcm herbal ion, make the active ingredient of medicine directly get disease institute, reach the purpose of treatment.
Removing blood stasis detumescence of the present invention is loose, and is the treatment rule according to the traditional Chinese medical science, according to principles of formulating prescriptions such as " monarch ", the science compatibility satisfies in the Chinese medicine compound between each medicine as far as possible, exists on effect and mutually promotes, complex relationships such as mutual restriction bring out the best in each other them, complement each other.Confirm that from clinical practice for many years removing blood stasis detumescence of the present invention is loose, and has remarkable efficacy such as curative effect weak point, instant effect, compare that its determined curative effect is obvious, and is economical convenient, is the external application of Chinese medicine medicine that the patient takes like a shot with the medicine of existing treatment chronic pelvic inflammatory disease.This medicine had not both had the hardship of the intestines and stomach stimulation, did not have pain of operation again, and had no side effect.
The specific embodiment:
Formula range of the present invention: its proportioning is a weight portion: Semen Persicae 30-60, Flos Carthami 40-80, Radix Angelicae Sinensis 50-90, Rhizoma Chuanxiong 50-70, Radix Salviae Miltiorrhizae 40-80, Cortex Moutan 50-100, Herba Leonuri 60-100, Herba Patriniae 50-100, Herba Lycopi's grass 40-80, Herba Lysimachiae 40-90, Rhizoma Cyperi 50-70, Radix Aucklandiae 50-80 12 flavor medicines are formed.
Example formulations one of the present invention: Semen Persicae 40g, Flos Carthami 60g, Radix Angelicae Sinensis 70g, Rhizoma Chuanxiong 60g, Radix Salviae Miltiorrhizae 60g, Cortex Moutan 70g, Herba Leonuri 70g, Herba Patriniae 70g, Herba Lycopi's grass 50g, Herba Lysimachiae 60g, Rhizoma Cyperi 50g, Radix Aucklandiae 60g.
Two of example formulations of the present invention: Semen Persicae 30g, Flos Carthami 40g, Radix Angelicae Sinensis 60, Rhizoma Chuanxiong 60g, Radix Salviae Miltiorrhizae 70, Cortex Moutan 80g, Herba Leonuri 70g, Herba Patriniae 90g, Herba Lycopi's grass 40g, Herba Lysimachiae 80g, Rhizoma Cyperi 60g, Radix Aucklandiae 50g.
Three of example formulations of the present invention: Semen Persicae 50g, Flos Carthami 70g, Radix Angelicae Sinensis 80g, Rhizoma Chuanxiong 60g, Radix Salviae Miltiorrhizae 60g, Cortex Moutan 80g, Herba Leonuri 60g, Herba Patriniae 80g, Herba Lycopi's grass 60g, Herba Lysimachiae 70g, Rhizoma Cyperi 60g, Radix Aucklandiae 80g.
The preparation method of this medicine and usage: will add medicine to preferred and by behind the prescription consumption proportion, purify brokenly, divide some equal portions, every part of about 130 grams, (cloth bag size about 26 * 16cm) standby in the cloth bag of making in advance of packing into.During use, adopt hot compress therapy, get the removing blood stasis detumescence and loose about 130g, add an amount of ethanol and mix thoroughly, the cloth bag of packing into, and cloth bag is steamed extremely diathermanous, be positioned over few abdomen, go up to umbilicus down to shame, about reach adnexa, carry out physical heating with the refreshing lamp of high bar China, temperatureization, (temperature is not scalded with heat and is advisable), got final product in time 40-50 minute, make Effective Components of Chinese Herb, through sick institute, thus reach the purpose of treatment.
From over 96 years, with removing blood stasis detumescence of the present invention is diffusing thousands of undergoing chronic pelvic inflammation to be treated, it is evident in efficacy.Calendar year 2001, the defeated ovarian cyst patient of the defeated ovum of 300 examples is carried out GP TH, paired observation, select for use the swollen treatment of loosing of removing blood stasis for (external therapy of Chinese herb group), select for use blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, alleviating pain and detumescence Chinese herbs decoction oral for (oral medicinal herb group), what select Western medicine antibiotics and Chymotrypsin or transparent fat acid enzyme for use is (Western medicine group), divide three groups of A, B, C, each 100.Follow up a case by regular visits to after three months, and contrast, existing that its contrast situation statistics is as follows:
Subordinate list:
Contrast statistical table total routine number cure rate % obvious effective rate % inefficiency % external application of Chinese medicine group 100 85 10 5 oral medicinal herb groups 100 40 40 20 Western medicine groups 100 42 38 20 model cases that divide into groups:
1, Xu Xirong, woman, 28, people from Wenzhou City.Over one year, lower abdomen often weighs down distending pain, and the waist sacrum is aching and tired, frequent micturition, and leucorrhoea grow in quantity, menoxenia is repeatedly through ultrasound diagnosis: the cystic mass that the visible size of right attachment area is 5.1 * 4.3cm.Prompting: ovarian cyst.Once repeatedly took western medicines in treatment, invalid, school repeatedly proposes excision, and the patient is reluctant to accept.Agree that through the patient accept removing blood stasis detumescence heat radiation and apply therapy, after 10 days, conscious each disease disappears, through ultrasound diagnosis: uterus and bilateral adnexa no abnormality seen.
2, Geng Ling, the woman, 25 years old, area just outside a city gate, Xinye County people from town, 2 years after marriage are infertile, and irregular menstruation is often felt abdominal pain with tenesmus, and the bilateral tenderness is obvious, and leucorrhea is many, and tired postemphasis repeatedly goes Salpingography, logical liquid art to show: bilateral obstruction of fallopian tube, hydrops.B ultrasonic prompting: pelvic hydrops, left ovary cyst, the about 6.8 * 4.3cm of size.Many tame hospitals suggestion operative treatment is because of patient's unpregnancy is reluctant to perform the operation.Agree through the patient, accept removing blood stasis detumescence heat radiation and apply therapy, successively treated for 2 weeks, conscious each transference cure is through ultrasound diagnosis: uterus bilateral adnexa no abnormality seen.Point out by Salpingography: the bilateral fallopian tube is unobstructed, no hydrops.Follow up a case by regular visits to pregnant nearly 2 months of patient after three months.
3, open change, woman, 16 years old, Xinye County one middle school student.Obvious, dripping lasting, the leucorrhoea grow in quantity of stomachache when menstruation comes over one year, lower abdomen tenderness are obvious, can touch enclosed mass, point outs through ultrasound diagnosis: pelvic hydrops, the big or small about 6.1 * 4.2cm of left ovarian cyst.Agree through the patient, accept removing blood stasis detumescence heat radiation and apply therapy.Successively treated for 2 weeks, point out through ultrasound diagnosis: uterus and adnexa no abnormality seen.
The consumption of medicine and usage: get removing blood stasis detumescence and loose about 130g, add an amount of ethanol and mix thoroughly, the cloth bag of packing into and manufacturing in advance steams to diathermanous, is positioned over few abdomen, go up to umbilicus down to shame, about reach adnexa, with the refreshing lamp heating of high bar China, temperature is boiling hot being advisable with heat.Got final product in time 40-50 minute, every day 2 times, the upper and lower noon, respectively once 7 days was a course of treatment.
Adnexa 1: the curative effect of the clinical use of Xinye County institute of traditional Chinese medicine proves.
Claims (4)
1, a kind of externally applied medicinal stasis-and swelling-eliminating powder for the treatment of chronic pelvic inflammatory disease, it is characterized in that: this medicine is made up of following Chinese herbal medicine proportioning, and wherein proportioning adopts weight portion: Semen Persicae 30-60, Flos Carthami 40-80, Radix Angelicae Sinensis 50-90, Rhizoma Chuanxiong 40-70, Radix Salviae Miltiorrhizae 40-80, Cortex Moutan 50-100, Herba Leonuri 60-100, Herba Patriniae 50-100, Herba Lycopi's grass 40-80, Herba Lysimachiae 40-90, Rhizoma Cyperi 50-70, Radix Aucklandiae 50-80 12 flavor medicines are formed.
2, the externally applied medicinal stasis-and swelling-eliminating powder of treatment chronic pelvic inflammatory disease according to claim 1, it is characterized in that: this medicine is made up of following Chinese herbal medicine proportioning, and its prescription consumption is: Semen Persicae 40g, Flos Carthami 60g, Radix Angelicae Sinensis 70g, Rhizoma Chuanxiong 60g, Radix Salviae Miltiorrhizae 60g, Cortex Moutan 70g, Herba Leonuri 70g, Herba Patriniae 70g, Herba Lycopi's grass 50g, Herba Lysimachiae 60g, Rhizoma Cyperi 50g, Radix Aucklandiae 60g.
3, the externally applied medicinal stasis-and swelling-eliminating powder of treatment chronic pelvic inflammatory disease according to claim 1, it is characterized in that: this medicine is made up of following Chinese herbal medicine proportioning, and its prescription consumption is: Semen Persicae 30g, Flos Carthami 40g, Radix Angelicae Sinensis 60, Rhizoma Chuanxiong 60g, Radix Salviae Miltiorrhizae 70, Cortex Moutan 80g, Herba Leonuri 70g, Herba Patriniae 90g, Herba Lycopi's grass 40g, Herba Lysimachiae 80g, Rhizoma Cyperi 60g, Radix Aucklandiae 50g.
4, the externally applied medicinal stasis-and swelling-eliminating powder of treatment chronic pelvic inflammatory disease according to claim 1, it is characterized in that: this medicine is made up of following Chinese herbal medicine proportioning, and its prescription consumption is: Semen Persicae 50g, Flos Carthami 70g, Radix Angelicae Sinensis 80g, Rhizoma Chuanxiong 60g, Radix Salviae Miltiorrhizae 60g, Cortex Moutan 80g, Herba Leonuri 60g, Herba Patriniae 80g, Herba Lycopi's grass 60g, Herba Lysimachiae 70g, Rhizoma Cyperi 60g, Radix Aucklandiae 80g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021358273A CN1186065C (en) | 2002-11-20 | 2002-11-20 | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021358273A CN1186065C (en) | 2002-11-20 | 2002-11-20 | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1435223A true CN1435223A (en) | 2003-08-13 |
| CN1186065C CN1186065C (en) | 2005-01-26 |
Family
ID=27628644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021358273A Expired - Lifetime CN1186065C (en) | 2002-11-20 | 2002-11-20 | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1186065C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125627A (en) * | 2010-10-27 | 2011-07-20 | 宋爱民 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation |
| CN103356975A (en) * | 2013-08-06 | 2013-10-23 | 河南中医学院 | Traditional-Chinese-medicine wax therapeutic tincture used for treating chronic pelvic inflammation |
| CN103495120A (en) * | 2013-10-09 | 2014-01-08 | 杨洁 | Chinese medicine composition for treating pelvic inflammation and preparation method thereof |
| CN104547690A (en) * | 2014-12-19 | 2015-04-29 | 王金英 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation after laparoscopy |
| CN104587399A (en) * | 2015-01-23 | 2015-05-06 | 青岛市中心医院 | Traditional Chinese medicine for treating ovarian cyst |
| CN106389557A (en) * | 2016-06-29 | 2017-02-15 | 上海市针灸经络研究所 | Traditional Chinese medicinal composition used for traditional Chinese medicinal moxibustion therapy as well as preparation method and applications of traditional Chinese medicinal composition |
| CN110882313A (en) * | 2019-12-09 | 2020-03-17 | 西安千禾药业股份有限公司 | Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof |
-
2002
- 2002-11-20 CN CNB021358273A patent/CN1186065C/en not_active Expired - Lifetime
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125627A (en) * | 2010-10-27 | 2011-07-20 | 宋爱民 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation |
| CN102125627B (en) * | 2010-10-27 | 2012-02-22 | 宋爱民 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation |
| CN103356975A (en) * | 2013-08-06 | 2013-10-23 | 河南中医学院 | Traditional-Chinese-medicine wax therapeutic tincture used for treating chronic pelvic inflammation |
| CN103495120A (en) * | 2013-10-09 | 2014-01-08 | 杨洁 | Chinese medicine composition for treating pelvic inflammation and preparation method thereof |
| CN103495120B (en) * | 2013-10-09 | 2015-09-09 | 杨洁 | A kind of Chinese medicine composition for the treatment of pelvic inflammatory disease and preparation method thereof |
| CN104547690A (en) * | 2014-12-19 | 2015-04-29 | 王金英 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation after laparoscopy |
| CN104587399A (en) * | 2015-01-23 | 2015-05-06 | 青岛市中心医院 | Traditional Chinese medicine for treating ovarian cyst |
| CN106389557A (en) * | 2016-06-29 | 2017-02-15 | 上海市针灸经络研究所 | Traditional Chinese medicinal composition used for traditional Chinese medicinal moxibustion therapy as well as preparation method and applications of traditional Chinese medicinal composition |
| CN106389557B (en) * | 2016-06-29 | 2019-07-09 | 上海市针灸经络研究所 | A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion |
| CN110882313A (en) * | 2019-12-09 | 2020-03-17 | 西安千禾药业股份有限公司 | Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof |
| CN110882313B (en) * | 2019-12-09 | 2021-12-21 | 西安千禾药业股份有限公司 | Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1186065C (en) | 2005-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN1255172C (en) | Medical paste for rheumatism and bone ache | |
| CN104644943A (en) | Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method | |
| CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1186065C (en) | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation | |
| CN103263601B (en) | Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation | |
| CN108295128B (en) | Traditional Chinese medicine compound preparation for treating rheumatoid arthritis and preparation method thereof | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN101703709A (en) | Chinese medicinal preparation for treating rheumatoid arthritis | |
| CN104107393A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN1290540C (en) | Oral admnistration Chinese medicine for treating bone fracture and matched topically applied Chinese medicine | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN101049413A (en) | Preparation of Chinese traditional medicine for treating barrenness caused by oviduct blocking | |
| CN104161996A (en) | Combined medicine for treating traumatic injury and preparation method of combined medicine | |
| CN103223147B (en) | Traditional Chinese medicinal formula for treating pelvic inflammation | |
| CN102895564A (en) | Chinese medicine for treating tubal nowhere and preparation method thereof | |
| CN1292764C (en) | Chinese medicinal pill for treating postpartum disease and gynecopathy | |
| CN1164324C (en) | Chiese medicine preparation for treating parenchyma pain | |
| CN110420305B (en) | Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof | |
| CN105770753A (en) | Traditional Chinese medicine composition for treating extrauterine pregnancy | |
| CN1294953C (en) | External Chinese materia medica preparation for treating leucoderma | |
| CN1171967A (en) | Medicinal liquid Yuyepizhengke for curing rheumatic arthritis | |
| CN103446292B (en) | Traditional Chinese medicine decoction for treating lumbocrural pains | |
| CN104721405A (en) | Orally taken traditional Chinese medicine for treating various stubborn dermatitis and psoriasis | |
| CN104688916A (en) | TCM (Traditional Chinese Medicine) composition for treating psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050126 |
|
| CX01 | Expiry of patent term |